Journal of Experimental Medicine · Published 2026-07-09 · DOI 10.1084/jem.20260054
Florence Assan, Margot Tragin, Sahiti Marella, Joanna Lipecka, Kévin Roger, Mohammed Zarhrate, Vincent Bondet, Vincent Nguyen, Fadela Akroun, Patrick Nitschké, Ida Chiara Guerrera, Christine Bole, Araksya Izmiryan, Maria Emilia Puig-Lombardi, Jennifer Fox, Joseph Kirma, Haihan Zhang, Yiqian Gu, Rachael Bogle, Katia Boniface, Julien Seneschal, Luis Seabra, Alice Lepelley, Marie-Louise Frémond, Nadège Bondurand, Emmauelle Jouanguy, Robert L. Modlin, Jean-Laurent Casanova, Jeremy Di Domizio, Michel Gilliet, Emilie Sbidian, Maxime Battistella, Emmanuel Mahé, Sarah Guégan, Lam C. Tsoi, Pascal Richette, Pascal Claudepierre, Arnaud Rigolet, Claire Giannesini, Antonio Costanzo, Darragh Duffy, Brad R. Rosenberg, Dharshini Sathishkumar, Emmanuelle Bourrat, Chung Hsing Chang, Alain Hovnanian, Johann E. Gudjonsson, Yanick J. Crow, Hervé Bachelez
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Assan, F., Tragin, M., Marella, S., et al. (2026). ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20260054